Stay updated on Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Sign up to get notified when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Updated from Revision: v3.0.1 to Revision: v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T21:45:23.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-07T18:12:57.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of new medical terms related to renal cell carcinoma and pembrolizumab. However, many related topics and previous location details have been removed.
    Difference
    2%
    Check dated 2025-08-31T12:23:49.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has added information related to Kidney Cancer on MedlinePlus, enhancing its core content.
    Difference
    0.2%
    Check dated 2025-08-24T08:08:32.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page has been updated to version 2.16.12, and the topic of Kidney Cancer has been removed from the content.
    Difference
    0.2%
    Check dated 2025-08-17T04:40:41.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated to include information on Kidney Cancer, and the version has been revised from v2.16.10 to v2.16.11.
    Difference
    0.2%
    Check dated 2025-08-10T00:31:33.000Z thumbnail image

Stay in the know with updates to Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.